Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease

Journal of Lipid Research

Volumn 53, Issue 7, 2012, Pages 1316-1326

  Amir, Shahzada ^a,b,c   Hartvigsen, Karsten ^a,b,d   Gonen, Ayelet ^c   Leibundgut, Gregor ^c   Que, Xuchu ^c   Jensen Jarolim, Erika ^a   Wagner, Oswald ^a   Tsimikas, Sotirios ^c   Witztum, Joseph L ^c   Binder, Christoph J ^a,b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Atherosclerosis; Autoantibodies; Biomarker; Mimotopes; Myocardial infarction; Oxidation specific epitopes; Oxidized LDL; Peptides; Phage display

Indexed keywords

ANTIGEN; AUTOANTIBODY; EPITOPE; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LOW DENSITY LIPOPROTEIN; LRO4 ANTIBODY; MALONALDEHYDE; MONOCLONAL ANTIBODY; PEPTIDE MIMOTOPE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; BACTERIOPHAGE; BLOOD ANALYSIS; CARDIOVASCULAR DISEASE; CELL SURFACE; CORRELATION ANALYSIS; HEART INFARCTION; HUMAN; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; STABLE ANGINA PECTORIS;

ANIMALS; AUTOANTIBODIES; CARDIOVASCULAR DISEASES; EPITOPES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; PEPTIDES; RECEPTORS, LDL;

EID: 84862315099     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M025445     Document Type: Article

References (45)

1. Binder, C. J., M. K. Chang, P. X. Shaw, Y. I. Miller, K. Hartvigsen, A. Dewan, and J. L. Witztum. 2002. Innate and acquired immunity in atherogenesis. Nat. Med. 8: 1218-1226. (Pubitemid 35373552)
2. Miller, Y. I., S. H. Choi, P. Wiesner, L. Fang, R. Harkewicz, K. Hartvigsen, A. Boullier, A. Gonen, C. J. Diehl, X. Que, et al. 2011. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108: 235-248.
3. Palinski, W., M. E. Rosenfeld, S. Yla-Herttuala, G. C. Gurtner, S. S. Socher, S. W. Butler, S. Parthasarathy, T. E. Carew, D. Steinberg, and J. L. Witztum. 1989. Low density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86: 1372-1376. (Pubitemid 19061548)
4. Ylä-Herttuala, S., W. Palinski, S. W. Butler, S. Picard, D. Steinberg, and J. L. Witztum. 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14: 32-40.
5. Ylä-Herttuala, S., W. Palinski, M. E. Rosenfeld, S. Parthasarathy, T. E. Carew, S. Butler, J. L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84: 1086-1095.
6. Tsimikas, S., W. Palinski, and J. L. Witztum. 2001. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21: 95-100. (Pubitemid 32061933)
7. Cyrus, T., D. Pratico, L. Zhao, J. L. Witztum, D. J. Rader, J. Rokach, G. A. FitzGerald, and C. D. Funk. 2001. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein E-deficient mice. Circulation. 103: 2277-2282. (Pubitemid 32433718)
8. Praticò, D., R. K. Tangirala, S. Hörkkö, J. L. Witztum, W. Palinski, and G. A. FitzGerald. 2001. Circulating autoantibodies to oxidized cardiolipin correlate with isoprostane F(2alpha)-VI levels and the extent of atherosclerosis in ApoE-deficient mice: modulation by vitamin E. Blood. 97: 459-464.
9. Gounopoulos, P., E. Merki, L. F. Hansen, S. H. Choi, and S. Tsimikas. 2007. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease. Minerva Cardioangiol. 55: 821-837. (Pubitemid 351169843)
10. Tsimikas, S. 2006. Oxidative biomarkers in the diagnosis and prognosis of cardiovascular disease. Am. J. Cardiol. 98: 9P-17P.
11. Ravandi, A., S. M. Boekholdt, Z. Mallat, P. J. Talmud, J. J. Kastelein, N. J. Wareham, E. R. Miller, J. Benessiano, A. Tedgui, J. L. Witztum, et al. 2011. Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study. J. Lipid Res. 52: 1829-1836.
12. Lopes-Virella, M. F., and G. Virella. 2010. Clinical significance of the humoral immune response to modified LDL. Clin. Immunol. 134: 55-65.
13. Tsimikas, S., E. S. Brilakis, R. J. Lennon, E. R. Miller, J. L. Witztum, J. P. McConnell, K. S. Kornman, and P. B. Berger. 2007. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J. Lipid Res. 48: 425-433. (Pubitemid 46220609)
14. Chou, M. Y., L. Fogelstrand, K. Hartvigsen, L. F. Hansen, D. Woelkers, P. X. Shaw, J. Choi, T. Perkmann, F. Backhed, Y. I. Miller, et al. 2009. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J. Clin. Invest. 119: 1335-1349.
15. Palinski, W., E. Miller, and J. L. Witztum. 1995. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc. Natl. Acad. Sci. USA. 92: 821-825.
16. Freigang, S., S. Horkko, E. Miller, J. L. Witztum, and W. Palinski. 1998. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler. Thromb. Vasc. Biol. 18: 1972-1982. (Pubitemid 28565762)
17. Binder, C. J., K. Hartvigsen, M. K. Chang, M. Miller, D. Broide, W. Palinski, L. K. Curtiss, M. Corr, and J. L. Witztum. 2004. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J. Clin. Invest. 114: 427-437. (Pubitemid 39071615)
18. George, J., A. Afek, B. Gilburd, H. Levkovitz, A. Shaish, I. Goldberg, Y. Kopolovic, G. Wick, Y. Shoenfeld, and D. Harats. 1998. Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 138: 147-152. (Pubitemid 28255163)
19. Fredrikson, G. N., I. Soderberg, M. Lindholm, P. Dimayuga, K. Y. Chyu, P. K. Shah, and J. Nilsson. 2003. Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol. 23: 879-884. (Pubitemid 36566181)
20. Zhou, X., G. Caligiuri, A. Hamsten, A. K. Lefvert, and G. K. Hansson. 2001. LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 108-114. (Pubitemid 32061934)
21. Tsimikas, S., A. Miyanohara, K. Hartvigsen, E. Merki, P. X. Shaw, M. Y. Chou, J. Pattison, M. Torzewski, J. Sollors, T. Friedmann, et al. 2011. Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J. Am. Coll. Cardiol. 58: 1715-1727.
22. Duryee, M. J., L. W. Klassen, C. S. Schaffert, D. J. Tuma, C. D. Hunter, R. P. Garvin, D. R. Anderson, and G. M. Thiele. 2010. Malondialdehyde- acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis. Free Radic. Biol. Med. 49: 1480-1486.
23. Binder, C. J., K. Hartvigsen, and J. L. Witztum. 2007. Promise of immune modulation to inhibit atherogenesis. J. Am. Coll. Cardiol. 50: 547-550.
24. Amir, S., and C. J. Binder. 2010. Experimental immunotherapeutic approaches for atherosclerosis. Clin. Immunol. 134: 66-79.
25. Tuominen, A., Y. I. Miller, L. F. Hansen, Y. A. Kesaniemi, J. L. Witztum, and S. Horkko. 2006. A natural antibody to oxidized cardiolipin binds to oxidized low-density lipoprotein, apoptotic cells, and atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 26: 2096-2102. (Pubitemid 44253794)
26. Hörkkö, S., D. A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J. A. Berliner, P. Friedman, E. A. Dennis, L. K. Curtiss, et al. 1999. Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins. J. Clin. Invest. 103: 117-128.
27. Palinski, W., S. Ylä-Herttuala, M. E. Rosenfeld, S. W. Butler, S. A. Socher, S. Parthasarathy, L. K. Curtiss, and J. L. Witztum. 1990. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10: 325-335.
28. Shaw, P. X., S. Hörkkö, S. Tsimikas, M. K. Chang, W. Palinski, G. J. Silverman, P. P. Chen, and J. L. Witztum. 2001. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo. Arterioscler. Thromb. Vasc. Biol. 21: 1333-1339.
29. Perschinka, H., B. Wellenzohn, W. Parson, R. van der Zee, J. Willeit, S. Kiechl, and G. Wick. 2007. Identification of atherosclerosis-associated conformational heat shock protein 60 epitopes by phage display and structural alignment. Atherosclerosis. 194: 79-87. (Pubitemid 47464310)
30. Petit, M. A., C. Jolivet-Reynaud, E. Peronnet, Y. Michal, and C. Trepo. 2003. Mapping of a conformational epitope shared between E1 and E2 on the serum-derived human hepatitis C virus envelope. J. Biol. Chem. 278: 44385-44392. (Pubitemid 37377187)
31. Binder, C. J., S. Hörkkö, A. Dewan, M. K. Chang, E. P. Kieu, C. S. Goodyear, P. X. Shaw, W. Palinski, J. L. Witztum, and G. J. Silverman. 2003. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med. 9: 736-743.
32. Tsimikas, S., H. K. Lau, K. R. Han, B. Shortal, E. R. Miller, A. Segev, L. K. Curtiss, J. L. Witztum, and B. H. Strauss. 2004. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein. Circulation. 109: 3164-3170.
33. Friguet, B., A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg. 1985. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77: 305-319. (Pubitemid 15103678)
34. Faghihnia, N., S. Tsimikas, E. R. Miller, J. L. Witztum, and R. M. Krauss. 2010. Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet. J. Lipid Res. 51: 3324-3330.
35. Tsimikas, S., C. Bergmark, R. W. Beyer, R. Patel, J. Pattison, E. Miller, J. Juliano, and J. L. Witztum. 2003. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. J. Am. Coll. Cardiol. 41: 360-370. (Pubitemid 36164488)
36. Shin, J. S., J. Yu, J. Lin, L. Zhong, K. L. Bren, and M. H. Nahm. 2002. Peptide mimotopes of pneumococcal capsular polysaccharide of 6B serotype: a peptide mimotope can bind to two unrelated antibodies. J. Immunol. 168: 6273-6278. (Pubitemid 34620047)
37. Dyson, H. J., and P. E. Wright. 1991. Defining solution conformations of small linear peptides. Annu. Rev. Biophys. Biophys. Chem. 20: 519-538.
38. Haro, I., and M. J. Gomara. 2004. Design of synthetic peptidic constructs for the vaccine development against viral infections. Curr. Protein Pept. Sci. 5: 425-433. (Pubitemid 39549430)
39. Chang, M. K., C. J. Binder, Y. I. Miller, G. Subbanagounder, G. J. Silverman, J. A. Berliner, and J. L. Witztum. 2004. Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J. Exp. Med. 200: 1359-1370. (Pubitemid 39657284)
40. Chang, M. K., C. Bergmark, A. Laurila, S. Hörkkö, K. H. Han, P. Friedman, E. A. Dennis, and J. L. Witztum. 1999. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl. Acad. Sci. USA. 96: 6353-6358. (Pubitemid 29256669)
41. Johnson, M. A., and B. M. Pinto. 2008. Structural and functional studies of peptide-carbohydrate mimicry. Top. Curr. Chem. 273: 55-116.
42. Buchwald, U. K., A. Lees, M. Steinitz, and L. A. Pirofski. 2005. A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice. Infect. Immun. 73: 325-333. (Pubitemid 40041124)
43. Harris, S. L., A. S. Dagtas, and B. Diamond. 2002. Regulating the isotypic and idiotypic profile of an anti-PC antibody response: lessons from peptide mimics. Mol. Immunol. 39: 263-272. (Pubitemid 35239884)
44. Monzavi-Karbassi, B., G. Cunto-Amesty, P. Luo, and T. Kieber-Emmons. 2002. Peptide mimotopes as surrogate antigens of carbohydrates in vaccine discovery. Trends Biotechnol. 20: 207-214. (Pubitemid 34270782)
45. Briley-Saebo, K. C., Y. S. Cho, and S. Tsimikas. 2011. Imaging of oxidation-specific epitopes in atherosclerosis and macrophage-rich vulnerable plaques. Curr. Cardiovasc. Imaging. Rep. 4: 4-16.